Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference111 articles.
1. Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein;Kaelin;Cancer,2009
2. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010;463:360–3.
3. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma;Gordan;Cancer Cell,2008
4. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer;Ferrara;Nat Rev Drug Discov,2004
5. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model;Xu;Cancer Res,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Speckle-Type POZ Protein Acts as a Predictive Biomarker for MTOR Target Therapy in Renal Cell Carcinoma;Current Science;2016-12-01
2. Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer;Nanomedicine: Nanotechnology, Biology and Medicine;2016-10
3. 2′-Hydroxyflavanone: A promising molecule for kidney cancer prevention;Biochemical Pharmacology;2015-08
4. Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model;International Journal of Biological Macromolecules;2014-05
5. A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy;Cancer;2014-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3